Table 1 RA patient demographic data, blood inflammatory parameters and treatment profile
Sex | Age | ESR (mm/h) | CRP (mg/l) | Hb (g/dl) | Platelets (× 109/l) | WBC (× 109/l) | Lymphocytes Neutrophils (× 109/l) | (× 109/) | Medication |
|---|---|---|---|---|---|---|---|---|---|
M | 71 | 58 | 60 | 12.7 | 351 | 10.3 | 7.8 | 1.7 | Diclofenac |
M | 53 | 93 | 36 | 10.3 | 417 | 10.5 | 8.4 | 1.5 | Methotrexate |
M | 78 | 57 | 74 | 12.4 | 422 | 7.8 | 5.5 | 1.5 | - |
M | 62 | 16 | 17 | 14.1 | 207 | 6.1 | 3.5 | 2 | - |
F | 61 | 37 | - | 12.3 | 261 | 6.1 | 3.9 | 1.6 | Leflunomide |
F | 75 | 61 | 77 | 11.6 | 246 | 6.5 | 5.3 | 0.8 | - |
F | 42 | 27 | 17 | 13.7 | 356 | 12.7 | 10.4 | 1.8 | - |
F | 63 | 49 | 45 | 11.1 | 359 | 5.8 | 4.7 | 0.6 | Clarithromycin |
F | 56 | 20 | - | 13.9 | 263 | 8 | 5 | 2.5 | Methotrexate, prednisolone, Losec, perindopril, Sinemet, aspirin |
F | 82 | 37 | - | 12 | 195 | 8.2 | 5.6 | 1.8 | - |
F | 63 | 41 | 41 | 11.4 | 309 | 9.8 | 9.6 | 3.3 | - |
F | 57 | - | 13.9 | - | - | - | - | - | Methotrexate, prednisolone, (depo-medrone) |
F | 76 | 57 | 72 | 11 | 244 | 7.7 | 6.3 | 0.9 | - |
F | 49 | - | - | 11.4 | 204 | 7.2 | 4.4 | 2.5 | Azothioprine, meloxicam |
F | 45 | 48 | - | 12.9 | 259 | 7.4 | 5.6 | 1.3 | Methotrexate, indomethacin |
F | 92 | 1 | - | 13.9 | 232 | 9.6 | 7.5 | 0.9 | Penicillamine |
F | 56 | 18 | - | 13.7 | 481 | 8.2 | 5.1 | 1.9 | Methotrexate, folic acid, prednisolone, Vioxx, antihypertensive treatment |
F | 44 | 7 | - | 13.2 | 241 | 7.1 | 4.8 | 1.3 | Leflunomide |
F | 68 | 12 | 5 | 12.7 | 284 | 6.9 | 4.6 | 1.7 | Azothioprine, prednisolone, alendronate, thyroxine, Losec |
F | 56 | 18 | 23 | 13.7 | 481 | 8.2 | 5.1 | 1.9 | - |
F | 78 | 12 | 5 | - | - | - | - | - | - |
F | 52 | 16 | 11 | - | - | - | - | - | Leflunomide |